← Leaderboards
Kimberly Wallace
Niaid Extramural Activities
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at Niaid Extramural Activities
Same institution · by research overlap
Others in their field
Top investigators on “Production”
- Eric S Lander · Whitehead Institute For Biomedical Res$568,626,051
- Bambra Strokes · Ppd Development Lp$526,656,217
- Richard A Gibbs · Baylor College Of Medicine$521,766,399
- Tracy L Nolen · Research Triangle Institute$451,761,218
- Sonia M Thomas · Research Triangle Institute$451,761,218
- David Heimbrook · Leidos Biomedical Research, Inc.$332,994,970
Research focus
ProductionLaboratoriesVaccinesPre-ClinicalProgramsClinicVaccine ProductionClinical TrialsPlantsLaboratory StudyGuanosine MonophosphateVector VaccineDesignContractsSafetyImmune ResponseManufacturing ProcessPlacebosAdenovirus VectorClinical Trials, Phase IPlasmid DnaClinical ResearchNational Institute Of Allergy And Infectious DiseaseHiv Vaccine
Grant awards (22)
Establishment of a Vaccine Pilot Plant$27,846,297
Z01 · FY2008 · AI · contact PI
Development And Production Of A Multiclade HIV-1 DNA Plasmid Vaccine$4,188,372
Z01 · FY2008 · AI · contact PI
Development And Production Of A Multicomponent Ebola rAd Vector Vaccine$2,785,478
Z01 · FY2008 · AI · contact PI
Development/production of H5 influenza DNA plasmid vaccine$2,219,937
Z01 · FY2008 · AI · contact PI
Development And Production Of Filovirus DNA Plasmid Vaccines$2,135,478
Z01 · FY2008 · AI · contact PI
Production of Alternate Adenovector Filovirus Vaccines$2,119,938
Z01 · FY2008 · AI · contact PI
Development/production of H3/H1 influenza DNA plasmid vaccine$2,119,938
Z01 · FY2008 · AI · contact PI
Development/production of a Marburg rAd Vaccine$2,119,937
Z01 · FY2008 · AI · contact PI
Development Of A Multicomponent HIV-1 Recombinant Adenoviral Vector Vaccine$1,938,372
Z01 · FY2008 · AI · contact PI
Development/Production-Alternative Serotype HIV Recombinant Adenoviral Vaccine$1,719,454
Z01 · FY2008 · AI · contact PI
Production of New Adenovector Constructs with Fiber-Shaft Modifications$1,619,454
Z01 · FY2008 · AI · contact PI
Establishment of a Vaccine Pilot Plant$38,128,374
Z01 · FY2007 · AI · contact PI
Development And Production Of A Multicomponent Ebola rAd Vector Vaccine$9,413,361
Z01 · FY2007 · AI · contact PI
Development And Production Of A Multiclade HIV-1 DNA Plasmid Vaccine$7,579,172
Z01 · FY2007 · AI · contact PI
Development/Production-Alternative Serotype HIV Recombinant Adenoviral Vaccine$5,602,987
Z01 · FY2007 · AI · contact PI
Development Of A Multicomponent HIV-1 Recombinant Adenoviral Vector Vaccine$4,294,474
Z01 · FY2007 · AI · contact PI
Development/production of H3/H1 influenza DNA plasmid vaccine$3,180,682
Z01 · FY2007 · AI · contact PI
Development/production of H5 influenza DNA plasmid vaccine$3,180,682
Z01 · FY2007 · AI · contact PI
Development/production of a Marburg rAd Vaccine$3,180,682
Z01 · FY2007 · AI · contact PI
Production of Alternate Adenovector Filovirus Vaccines$1,590,341
Z01 · FY2007 · AI · contact PI
Development And Production Of Filovirus DNA Plasmid Vaccines$1,590,341
Z01 · FY2007 · AI · contact PI
Production of New Adenovector Constructs with Fiber-Shaft Modifications$1,113,792
Z01 · FY2007 · AI · contact PI